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Abstract
Background: This study was conducted to evaluate the initial and mid-term patency rates of 
chronic total femoropopliteal artery (FPA) occlusions treated by subintimal angioplasty (SIA) 
and stenting.
Methods: From March 2010 to February 2013, 74 patients were included in the study. Se-
venty two patients with total occlusion of the FPA and good distal runoff (2 or 3 patent vessels) 
were treated with percutaneous SIA and stenting. All patients had severe claudication or cri-
tical limb ischemia. In all cases, the procedure was performed with a contralateral approach. 
Follow-up was done at 6 months with clinical evaluation and color-Doppler. If it was necessary, 
peripheric angiography was performed.
Results: Immediate technical success was achieved in 72 (97%) patients. Two (3%) distal 
embolizations, 2 (3%) groin hematomas, 1 (1%) femoral pseudoaneurysm and 1 (1%) rupture 
of the junction-external iliac-superficial femoral artery occurred. All of the complications were 
treated successfully. Total occlusion in 1 patient and critical occlusion in 3 patients were showed 
at the 6th month. Patency rate at the sixth month was 94% with a stent length of 13.4 ± 8.2 cm.
Conclusions: Percutaneous SIA and stenting for chronic total of the FPA occlusion showed 
good initial and mid-term patency rates, with few periprocedural complications. (Cardiol J 
2015; 22, 1: 115–120)
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Introduction
Endovascular treatment of occlusive periphe-
ral arterial disease has been markedly increased 
in the last decade in cases of critical limb ischemia 
of lower extremity arteries or claudicants. Several 
techniques have been improved to achieve higher 
procedural success and patency rates especially 
in chronic total occlusions of superficial femoral 
or popliteal arteries since its first description by 
Bolia et al. in 1989 [1, 2].
Subintimal angioplasty (SIA) has been used 
as an acceptable and effective technique which 
allows recanalization of long diffuse chronic total 
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occlusions in superficial femoral and popliteal 
arteries. SIA has previously been used as as an 
alternative to conventional percutaneous translu-
minal angioplasty (PTA) when the latter technique 
fails. There is also a group of patients with critical 
lower limb ischemia and significant co-morbidities 
who are not eligible for surgical interventions. 
Revascularization with SIA offers reduced rates 
of amputations and improves wound healing in pa-
tients with critical limb ischemia (CLI) in addition 
to improvement in claudication status in this group 
of patients [3–6]. Although SIA has been accepted 
as a successful technique especially in long chronic 
femoropopliteal occlusions, low patency rates 
compared with surgical bypass (56–70% at 1 year 
follow-up) remain the main criticism regarding its 
independent use  [7–9]. However, revascularization 
by SIA leads to high limb salvage rates in patients 
with CLI indicating that reocclusion incidences did 
not exactly reflect clinical outcomes. Patency rates 
which are closely related to relief of symptoms 
in claudicants may also be improved by SIA, but 
in contrast to CLI patients, patency status of the 
artery determines the clinical success provided by 
the intervention.
The loss of the patency following intervention 
is multifactorial. Renal disease, diabetes mellitus, 
smoking, occlusion length and the number of distal 
runoff arteries are factors that adversely affect 
primary and long-term patency rates following SIA 
[10–12]. According to previous reports in the litera-
ture, high rate of occlusion occurs early during the 
first 6 months suggesting that the reocclusion may 
be related to elastic recoil with residual stenosis 
and/or flow limiting spiral dissection [13].
Based on these data, it may be suggested 
that the routine adjunction of stents to subintimal 
recanalization could provide improvement of pa-
tency and clinical outcomes by optimization of the 
SIA technique. We aimed to evaluate the clinical 
outcomes and mid-term patency rates following 
SIA and stenting of chronic occlusions in long 
femoropopliteal lesions.
Methods
Study population
The study was a prospective single center 
study including patients with either severe, life-
style limiting intermittent claudication or CLI pre-
senting with at least one chronic total occlusion 
of the superficial femoral artery (SFA) and/or po-
pliteal artery with good distal runoff. The clinical 
severity of the claudication and limb ischemia was 
defined according to the Rutherford classifica- 
tion [14]. Between March 2010 to February 2013, 
74 patients with angiographically documented 
chronic total occlusion in the femoropopliteal ar-
teries (SFA plus popliteal) and at least a 6-month 
history of intermittent claudication and/or CLI 
were included in the study. All of the participants’ 
clinical status varied between Rutherford cate-
gories 1 to 6 which was previously defined [14]. 
Successful intraluminal wire passage through the 
lesion, history of severe contrast allergy or hy-
persensitivity, hypersensitivity to aspirin and/or 
clopidogrel, systemic coagulopathy or hypercoa-
gulation disorders and acute limb ischemia were 
excluded. All of the patients gave written infor-
med consent and the study was approved by the 
local Ethics Committee.
Procedure
All the patients were premedicated with dual 
anti-platelet therapy (aspirin 100 mg/day plus clopi-
dogrel 75 mg/day) for 3 days before the procedure. 
After contralateral femoral puncture and insertion of 
a 7 F sheath, intra-arterial bolus of 5,000 IU heparin 
was injected to maintain an activated clotting time 
> 200 s. SIA was performed as previously described 
by Bolia [1, 2]. Entry transition to the subintimal 
space and re-entry to the intraluminal space was 
performed using a soft angled tip or j-tip hydrophilic 
0.035-inch Raptor guidewires (InSitu, USA) with 
support of a 6.5 F Sheathless guide catheter (Asahi, 
Japan). The guidewire was advanced with a looped 
shape through the subintimal space. If the penetra-
tion was not achieved by the hydrophilic guidewire, 
stiffer and more steerable wires such as 0.018 inch 
Treasure (12 g–180/300 cm) or 0.014/0.018 inch 
Astato (20 or 30 g–180/300 cm) wires were used. 
After confirmation of successful distal re-entry, stan-
dard dilatation of the target lesion was performed 
using appropriately sized GliderfleX balloon catheter 
(TriReme Medical, USA). Then, self-expandable ni-
tinol stents (Polaris, QualiMed, Germany) were im-
planted to cover the entire lesion. The stent size was 
determined to be 1 to 2 mm larger than the reference 
vessel diameter and subsequent post-dilatation 
of stents was performed to all cases (Figs. 1, 2). 
After completion of the procedure, all patients were 
prescribed to dual antiplatelet therapy with aspirin 
plus clopidogrel for 6 months and aspirin 100 mg/day 
indefinitely after the 6th month.
Follow-up
Patients were evaluated with physical exami-
nation and duplex scanning of the treated artery 
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before discharge and 6 months after discharge. 
Peripheral angiography was performed when the-
re was evidence of a hemodynamically significant 
stenosis identified by duplex scan.
Definitions
Primary patency was defined as a treated 
vessel without a significant restenosis or a need 
for repeat revascularization. Secondary patency 
was defined as a target vessel that subsequently 
became totally occluded and was reopened by 
repeat revascularization. Technical success was 
defined as a stenosis less than 30% on completion 
angiography and velocity ratio on duplex scan less 
than 1.5 comparing the treated artery with the pro-
ximal patent vessel. Absence of flow determined by 
duplex scan indicated occlusion or total restenosis 
following revascularization.
Systolic velocity greater than 200 cm/s and 
a ratio of greater than 2.5 indicated restenosis of 
the target vessel. Periprocedural complications 
included death, acute myocardial infarction, stro-
ke within 48 h after the procedure, rupture of 
the target vessel, bleeding which requires blood 
transfusion, distal embolization, retroperitoneal 
hematoma, pseudoaneurysm and other access site 
complications such as groin hematoma.
Statistical analysis 
Quantitative values are expressed as mean ± 
± standard deviation. The Statistical Package for 
Social Sciences (SPSS) statistical software packa-
ge (version 10.0, Inc., Chicago, USA) was used to 
perform all statistical calculations.
Figure 1. Subintimal angioplasty of a flush occlusion 
of the superficial femoral artery (SFA) performed via 
a contralateral common femoral artery approach. Prein-
tervention angiogram of the SFA origin (A). Preinterven-
tion angiogram of the reconstituted popliteal artery, just 
above the knee joint (B). Initiation of the subintimal dis-
section with creation of the wire loop (C). The wire has 
re-entered the popliteal artery lumen with the glide mic-
rocatheter before expansion (D).
Figure 2. Subintimal angioplasty and stenting of a flush 
occlusion of the superficial femoral artery (SFA) perfor-
med via a contralateral common femoral artery appro-
ach (A). Completion angiogram showing patent SFA, 
popliteal, tibial perineal trunk, posterior tibial, and ante-
rior tibial arteries (B, C, D).
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Results
Seventy four patients with a mean age of 
65.4 ± 15.2 years underwent SIA plus stenting for 
chronic total occlusions of femoropopliteal arteries. 
Patient baseline characteristics showed that 43% of 
the participants were male, 73% were active smo-
kers, 65% were diabetic, 76% had hypertension, 
49% had concomitant coronary artery disease and 
43% had hyperlipidemia. According to Rutherford 
classification [14], 21 (28%) patients were included 
in categories 1–3. Patients with ischemic rest pain 
and limb ulceration consisted of 14 (19%) and 
15 (20%) participants, respectively. Eight (11%) 
of the patients had gangrene or tissue loss in the 
study group. Table 1 demonstrates demographic 
and clinical characteristics of the patients.
The initial procedural success was achieved in 
72 of 74 cases (97%). SIA and stenting did not suc-
ceed in 2 of 74 patients (3%). All the lesions were 
revascularized by SIA and stenting in 72 patients. 
Target lesions were located in the SFA in 55% of 
the patients (40 of 72 cases). The remaining lesion 
localizations were 42% in femoropopliteal and 3% 
in popliteal (only) arteries respectively. The mean 
stent length was 13.4 ± 8.2 cm and the mean stent 
diameter was 6.9 ± 2.6 mm. In 36 cases (50% of 
the patients), stent overlapping was performed to 
cover the entire lesion. Table 2 displays procedural 
characteristics of the study population.
There were no procedure related deaths in 
the study group. Complications were limited to 
distal embolus, groin hematoma, femoral pseudo-
aneurysm, and rupture of SFA-external iliac artery 
junction. There was no retroperitoneal hematoma 
observed. Distal embolization leading to acute limb 
ischemia (2 patients, 3%) was managed by intra-
-arterial thrombolysis (alteplase/tissue plasminogen 
activator, Actilyse) and recanalization was maintained 
by fibrinolysis and limb salvage was achieved. No 
blood transfusion or surgical therapy was required in 
patients with groin hematomas (2 cases, 3%). Only 
1 (1%) of the patients exhibited femoral pseudoan-
eurysm which was treated via ultrasound directed 
thrombin injection. Rupture of the SFA-external iliac 
artery junction was observed in 1 (1%) patient who 
was successfully treated by implantation of graft cove-
red stent during the procedure. Table 3 summarizes 
Table 3. Clinical conditions complicating the procedures.
Complications N (%) Modality of treatment
Distal embolus 2 (3%) Treated with thrombolysis
Groin hematoma 2 (3%) Managed by observation
Femoral pseudoaneurysm 1 (1%) Treated with ultrasound directed thrombin injection
Retroperitoneal hematoma 0 (0%)
Ruptured junction of SFA-external iliac artery 1 (1%) Treated with graft-covered stent during procedure
SFA — superficial femoral artery
Table 1. Demographic and clinical characteristics 
of patients (n = 74).
Variable N (%)
Age [years] 65.4 ± 15.2
Male gender 32 (43%)
Critical limb ischemia (Rutherford  
categories; 3–6)
16 (22%)
Rest pain 14 (19%)
Ulceration 15 (20%)
Gangrene 8 (11%)
Claudication (Rutherford  
categories; 1–3)
21 (28%)
Coronary artery disease 36 (49%)
Hyperlipidemia 32 (43%)
Hypertension 56 (76%)
Diabetes mellitus 48 (65%)
Smoking 54 (73%)
Renal insufficiency 8 (11%)
Table 2. Procedural characteristics of the study 
population (n = 72).
Variable N (%) 
Location of SIA and stenting
SFA only 40 (55%)
SFA-popliteal 30 (42%)
Popliteal only 2 (3%)
Number of stents 156
Stent length 13.4 ± 8.2
Stent diameter 6.9 ± 2.6
Stent overlap 36 (50%) 
SIA — subintimal angioplasty; SFA — superficial femoral artery
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complications and the applied treatment modalities 
following the procedures.
The procedural success for SIA and stenting 
was achieved in majority of patients (72 patients, 
97%). The procedural failure was observed in only 
2 (3%) patients. The follow-up period was 6 months 
for all the patients following femoropopliteal SIA 
and stenting. At the end of the 6-month period, 
4 (5%) amputations were observed. Only 1 (1%) 
case displayed total occlusion of the target vessel 
and 3 (4%) patients exhibited critical stenosis in 
already revascularized vessels (Table 4).
Discussion
Chronic total occlusions of femoropopliteal 
segment account for a significant portion of pe-
ripheral vascular lesions which represent chal-
lenging technical periprocedural problems that 
have to be overcome by the interventionalists. 
PTA of long SFA occlusions with an intraluminal 
approach usually requires long time consuming 
procedures, use of excess equipment, and high 
volume experienced operators. Technical failure of 
intraluminal angioplasty is mostly attributed to long 
segment occlusions [15]. In cases of occlusions 
> 10 cm long, the primary patency rate of intr-
aluminal angioplasty with stents was < 30% [16]. 
Subintimal recanalization with distal re-entry has 
been successfully used since it has been defined 
by Bolia et al. [1, 2]. London et al. [17] reported 
a 90% technical success rate for SIA of SFA in 
a series of patients with a mean occlusion length of 
15 cm. Recently, Soga et al. [18] have published the 
initial and 3-year results of 902 patients undergoing 
SIA vs. intraluminal angioplasty with stenting in 
long femoropopliteal occlusions and declared that 
patency rates were similar in either approaches. 
The investigators of this study also reported lon-
ger procedure time and high crossover rates in 
intraluminal approach group, so SIA with stenting 
was suggested to be preferred in the treatment 
of long femoropopliteal occlusions [18]. SIA is 
performed by creating an extraluminal channel be-
tween intimal and medial layers of the artery which 
contains little atherosclerotic plaque or thrombus. 
The relatively low content of thrombus or plaque 
burden also makes SIA more advantageous than the 
intraluminal approach. Previous studies reveal high 
technical success rates ranging from 74% to 92% 
with few complications [19]. The most technical 
failures reported previously were due to failure 
to pass wire into the extraluminal space or re-
-entry into the true lumen. We experienced a high 
technical success rate (97%) and the remaining 
unsuccessful cases were mainly associated with 
extreme calcification that prevents re-entry into 
the distal true lumen. The complications reported 
in previous reports were perforation, vessel ruptu-
re, distal embolization and occlusion of collaterals 
mostly without a need for surgical repair [20, 21]. 
We have experienced 1 (1%) vessel rupture which 
was treated by implantation of a covered stent. 
Distal embolization occurred in 2 (3%) cases and 
was managed by catheter directed thrombolysis. 
A bolus of 1 mg tissue plasminogen activator (t-PA) 
was given into the infusion catheter and 1 mg/h 
t-PA was administered for 12 h in cases of acute 
distal embolization. The next day following throm-
bolysis, an angiography was performed to see the 
final flow in the artery.
Several studies have been conducted on the 
endovascular treatment of SFA occlusions > 10 cm 
in length and angioplasty alone was used achieving 
a mean primary patency rate of 46% at 12 months 
[22–24]. Other studies have reported the results 
of bail-out stenting strategies (stenting performed 
if only angioplasty alone fails) which reveal a mean 
primary patency rate of 55% at 12 months [25–28].
A meta-analysis by Muradin et al. [29] declared 
that there is no substantial difference between 
angioplasty alone and stenting in terms of long-
-term patency rate, whereas in the treatment 
of long SFA occlusions, stenting is superior to 
angioplasty to gain better patency outcomes. The 
use of stents in SFA has lowered the incidence of 
early stenoses which is mostly due to elastic re-
coil, residual lesion, and flow limiting dissections 
even in calcified complex arteries [30]. However, 
despite these results, routine stenting of SFA 
occlusions remains controversial because of the 
development of intimal hyperplasia leading to in-
-stent restenosis which dominantly occurs in long 
lesions or in multiple stents deployed [31]. Boufi 
et al. [32] have recently presented the long term 
Table 4. Outcome of femoropopliteal subintimal 
angioplasty (SIA) and stenting at initial and the  
6th month.
Variable N (%)
Successful initial SIA and stenting 72 (97%)
Unsuccessful initial SIA and stenting 2 (3%)
Total restenosis (occlusion)  
at the 6th month
1 (1%)
Critical stenosis at the 6th month 3 (4%)
Total amputations 4 (5%)
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results of SIA plus stenting in a homogenous series 
of claudicants with femoropopliteal occlusions and 
declared that SIA plus stenting is an effective and 
useful option for the management of claudicants 
with femoropopliteal occlusions which may be 
considered complementary to surgical bypass. 
Our findings are partly consistent with this study 
which indicates stenting combined with SIA as 
a valuable revascularization strategy for these long 
diffuse occlusions with the use of new stents which 
are more durable against mechanic forces. We have 
to point out that the follow-up period should be 
longer to see the late term outcomes in terms of 
restenosis or re-occlusions as a study limitation.
Conclusıons
Percutaneous SIA and stenting of chronic long 
femoropopliteal occlusions show good initial and 
mid-term patency rates. Complication rates are 
also favorable compared with other revasculari-
zation options such as surgery or percutaneous 
luminal angioplasty with or without stenting.
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